Portal de Periódicos da CAPES

Hemoptysis? Try Inhaled Tranexamic Acid

2018; Elsevier BV; Volume: 54; Issue: 5 Linguagem: Inglês

10.1016/j.jemermed.2018.01.029

2352-5029

Stephanie Komura, Robert M. Rodriguez, Christopher R. Peabody,

Pulmonary Hypertension Research and Treatments

Abstract Background Tranexamic acid (TXA) is a synthetic anti-fibrinolytic agent used to prevent and treat various bleeding complications. In many studies, investigators have evaluated its utility and safety orally, intravenously, and topically, but few studies have described the potential benefits of nebulized TXA. Case Report We present a case of massive hemoptysis treated with nebulized TXA in the emergency department (ED) that led to the cessation of bleeding and avoidance of endotracheal intubation. Why Should an Emergency Physician Be Aware of This? In massive hemoptysis, rapidly available nebulized TXA may be considered a therapeutic option, serving either as primary therapy or as a bridge until other definitive therapies can be arranged.